En Es
Categories

LumiraDx

LumiraDx develops, manufactures and commercializes industry-leading point of care (POC) diagnostic platforms that use cloud-based platforms to integrate health system networks and transfer patient data.
Products Covid-19Summary
Close

Covid-19 LumiraDx

Clinical Laboratory

SARS-CoV-2 Ab Test
LumiraDx SARS-CoV-2 Ab Test

The LumiraDx SARS-CoV-2 Ab Test is a microfluidic immunofluorescence assay for qualitative detection of total antibodies to SARS-CoV-2 in human whole blood (capillary fingerstick or venous), plasma or serum for indication of recent or prior infection. Used with the LumiraDx Platform the Test delivers rapid results at the point of care.
More details

SARS-CoV-2 Ag Pool Test
LumiraDx SARS-CoV-2 Ag Pool Test

The LumiraDx SARS-CoV-2 Ag Pool Test is a rapid microfluidic immunofluorescence assay for the qualitative detection of the nucleocapsid protein antigen in nasal or nasopharyngeal swab specimens pooled from up to 5 individuals suspected of COVID-19 or up to 5 asymptomatic individuals. Used with the LumiraDx Platform the test offers a rapid, scalable and cost-effective screening solution for infectious individuals.
More details

SARS-CoV-2 Ag Test
LumiraDx SARS-CoV-2 Ag Test

The LumiraDx SARS-CoV-2 Ag Test is a microfluidic immunofluorescence assay for the direct and qualitative detection of nucleocapsid protein antigen in nasal swab specimens collected from individuals suspected of COVID-19 by their healthcare provider within the first twelve days of symptom onset. Used with the LumiraDx Platform the test delivers rapid results at the point of care.
More details

Point Of Care Diagnostic System
LumiraDx

The LumiraDx Platform is an innovative, next generation point of care diagnostic system that combines a small, portable instrument, advanced low cost test strip and seamless digital connectivity. This allows healthcare professionals to perform tests using small sample volumes and to view results quickly on the instrument touchscreen. The LumiraDx Instrument is intended for multi patient use.
More details
Close

About LumiraDx

LumiraDx develops, manufactures and commercializes industry-leading point of care (POC) diagnostic platforms that use cloud-based platforms to integrate health system networks and transfer patient data.
FaceBook Twitter Google+ Linked in
D-Dimer Test

D-Dimer Test

Model: LumiraDx D-Dimer Test
Request Information

Description:

The LumiraDx D-Dimer Test is an easy to use fluorescence immunoassay designed to rapidly quantify D-Dimer levels in human whole blood and plasma at the point of care. It is the first quantitative micro-fluidic immunoassay of its kind, providing a precise and accurate D-Dimer result from a single direct fingerstick blood sample, in only six minutes.

Features Specifications

Features

• Fast, accurate, quantitative results in just 6 minutes
• Direct fingerstick sampling
• Only 15µL sample volume required
• Room temperature Test Strip storage
• Precision: ≤11.1% CV Request Information

Specifications

• Displayed results: D-Dimer FEU (Fibrinogen Equivalent Units) μg/L
• Storage temperature: 2–30 °C (36-86 °F)
• Operating temperature: 15–30 °C (59–86 °F)
• Measuring range: 190–4000 μg/L FEU. Each laboratory should investigate the transferability of the expected values to its own patient population and, if necessary, determine its own reference ranges.
• Sample type: Whole blood (capillary fingerstick and sodium citrated venous) and sodium citrated plasma samples
• Sample size: 15 μL
• Time to result: Approximately 6 minutes Request Information

Send A Message To This Supplier

* Required Information
* Email
To
LumiraDx (D-Dimer Test)
* Message

Copyright © 2000-2022 TradeMed.com. All rights reserved. | Terms And Conditions